Caricamento...
Considerations for designing preclinical studies in cancer immune nanomedicine
Immunotherapy is known to be clinically beneficial for patients with cancer and has in many cases become the new standard of care. Because of this success, the interest in integrating nanomedicine with cancer immunotherapy has grown to further improve clinical response and toxicity profiles. However...
Salvato in:
| Pubblicato in: | Nat Nanotechnol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8103921/ https://ncbi.nlm.nih.gov/pubmed/33349682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41565-020-00817-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|